Aravis Overview

  • Investor Type
  • Growth/​Expansion

  • Status
  • Active

  • Professionals
  • 4

Professionals

  • Investments
  • 50

  • Portfolio
  • 3

  • Exits
  • 37

Exits

Aravis General Information

Company Description

Founded in 2001, Aravis is a growth and expansion firm based in Zurich, Switzerland. The firm invests in companies operating in biotech, oncology, autoimmune diseases, personalized treatments, digital healthcare, blockchain, machine learning, artificial intelligence, internet of things, virtual and augmented reality, face recognition, gaming, advanced sensors, composite materials, agricultural disruption, special situations, and smart distribution systems sectors.

Business Details

Website
www.aravis.ch
Year Founded
2001
Investor Status
Actively Seeking New Investments
Trade Association
Swiss Private Equity & Corporate Finance (SWPE)
Primary Investor Type
Growth/Expansion
Other Investor Types
Infrastructure
PE/Buyout
Venture Capital
Corporate Office
  • Merkurstrasse 70
  • 8032 Zurich
  • Switzerland
+41 043

Aravis Investments (50)

Aravis’s most recent investment was a with Hedera-22 for . The deal was made on 14-Aug-2024.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Hedera-22 14-Aug-2024 Biotechnology Generating Revenue
Bird Rock Bio 01-Oct-2016 Drug Discovery Clinical Trials - Phase 2
Bird Rock Bio 03-Apr-2015 Drug Discovery Clinical Trials - Phase 2
Urogen Pharma 06-Jun-2014 Drug Delivery Generating Revenue/Not Profitable
Synaffix 19-Feb-2014 Early Stage VC Discovery Tools (Healthcare) Generating Revenue
You’re viewing 5 of 50 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aravis Exits (37)

Aravis has made a total of 37 exits. Its latest exit was from Bird Rock Bio for on 18-Aug-2023. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size
Bird Rock Bio 18-Aug-2023
Synaffix 31-May-2023
Light Chain Bioscience 01-Jun-2021
Marinomed Biotech 01-Feb-2019
Symetis 16-May-2017 Merger/Acquisition
You’re viewing 5 of 37 exits. Get the full list »

Aravis Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Aravis‘s full profile, request access.

Request a free trial

Aravis Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Aravis FAQs

  • What is Aravis?

    Founded in 2001, Aravis is a growth and expansion firm based in Zurich, Switzerland.

  • When was Aravis founded?

    Aravis was founded in 2001.

  • Where is Aravis headquartered?

    Aravis is headquartered in Zurich, Switzerland.

  • What is Aravis's total asset value?

    Aravis has around in total assets under management.

  • How many investments has Aravis made?

    Aravis has made 50 investments.

  • What has Aravis invested in?

    Aravis has made numerous investments in companies like Hedera-22, Bird Rock Bio, and Urogen Pharma within the Biotechnology, Drug Discovery, and Drug Delivery industries.

  • What has Aravis invested in recently?

    Aravis's latest investment was on 14-Aug-2024 in Hedera-22, a company within the Biotechnology industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »